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Abstract
The prevalence of antimicrobial resistant bacteria has been increasingly monitored in animals in order to prevent the spread 
of these strains through the food supply chain. Particularly, the emergence of vancomycin-resistant Enterococcus and 
Extended-spectrum beta-lactamases (ESBL) producing Enterobacteriaceae has been investigated worldwide. In the current 
study, the frequency of antimicrobial resistance of generic Escherichia coli and Enterococcus isolated from swine carcasses 
sampled at the pre-chill stage was assessed. A total of 319 strains of E. coli and 240 strains of Enterococcus sp. from carcasses 
sampled in three Brazilian slaughterhouses were tested by the agar diffusion test, according to the guidelines of Clinical and 
Laboratory Standards Institute. Escherichia coli strains showed high frequency of resistance against tetracycline (79.3%), 
ampicillin (64.3%), sulfonamide and florfenicol (64.9%). Five isolates were resistant to either cefotaxime or ceftazidime, but 
only one of them displayed a positive result in the confirmatory phenotypic test recommended by CLSI. The five isolates 
were subjected to PCR for detection of blaTEM and blaPSE genes and three strains presented amplification for blaTEM. The 
most prevalent resistance profiles found among Enterococcus strains were tetracycline (42.5%), erythromycin (26.7%) and 
high level streptomycin (HLAR, 20.4%). All isolates were susceptible to vancomycin, teicoplanin and ampicillin. Minimum 
inhibitory concentration (MIC) was determined for resistant and intermediate erythromycin Enterococcus strains. The 
determined MIC ranged from 1 µg/mL to 4 µg/mL for erythromycin intermediate strains, while among the resistant strains 
it ranged from 6 µg/mL to >256 µg/mL. The results indicate that vancomycin-resistant Enterococcus isolates are not prevalent 
in pig carcasses; however ESBL producing E. coli may be present.
Introduction
Monitoring of antimicrobial resistance in pathogenic or commensal bacteria is essential to evaluate the risk of antimicrobial 
resistance genes spread through the food supply chain. Resistant bacteria present on carcasses that were able to surpass the 
food processing hurdles, may colonize the consumer’s gastrointestinal tract (Apley, 2001). In particular, extended-spectrum 
β-lactamases (ESBL) resistant bacteria and vancomycin-resistant Enterococcus have been investigated worldwide, due to its 
importance for human therapy. Therefore, the aim of this study was to investigate the frequency of antimicrobial resistance 
in Escherichia coli and Enterococcus sp. isolated from pig carcasses sampled at the pre-chill stage.
Material and Methods
Two sampling cycles were conducted in three slaughterhouses located in the state of Santa Catarina, Brazil. A total of 252 
pre-chill carcasses were sampled by rubbing individual sterile sponges (Nasco ®) on a 400 cm²-carcass area (Brazil, 2007). 
After the addition of 40 ml of Buffered Peptone Water (BPW 0.1%) to each sample, aliquots were transferred to Violet 
Red Bile Agar (Oxoid Brazil Ltda.) and KF Streptococcus Agar (Bento, Dickson & Company) for isolation of E. coli and 
Enterococcus sp., respectively. After incubation (37ºC/48h) typical colonies were identified according to Quinn et al. (2011). 
The Enterococcus genus was confirmed by amplification of tuf gene (Ke et al., 1999) and the identification of E. faecalis was 
performed by amplification of ddlE.faecalis gene (Dutka-Malen et al. 1995).
The isolates were tested for antimicrobial resistance by disk-diffusion test in Müller-Hinton Agar (Oxoid), performed and 
interpreted according to “Clinical and Laboratory Standards Institute”, document M100-S22 and M31-A2 (CLSI, 2008; 
2012). Escherichia coli strains were tested using disks (Oxoid) of the following antimicrobials: ampicillin (10μg), ceftazidime 
(30μg), cefotaxime (30μg), gentamicin (10μg), florfenicol (30μg), nalidixic acid (30μg) tetracycline (30μg) and sulfonamide 
(300μg). Resistant strains to cefotaxime and/or ceftazidime were confirmed phenotypically for ESBL resistance, using 
disks of cefotaxime and ceftazidime alone and in combination with clavulanic acid (CLSI, 2012).  Additionally, genotypic 
confirmation was conducted by PCR-detection of genes blaTEM and blaPSE (Sandvang et al. 2002). The Enterococcus isolates 
were tested against: ampicillin (10μg), ciprofloxacin (5μg), chloramphenicol (30μg), erythromycin (15μ), teicoplanin 
(30μg), tetracycline (30μg), vancomycin (30μg), streptomycin (300μg) and gentamicin (120μg). For isolates displaying 
erythromycin intermediate and resistant profiles, the minimum inhibitory concentration (MIC) was determined, using the 
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Etest® (BioMerieux). The frequency of E.coli and Enterococcus resistant strains among slaughterhouses was compared by chi-
square, using the software SPSS 1.8 with a confidence level of 95%.
Results
From 319 tested E. coli strains, 12.8% were susceptible to all antimicrobials. The highest frequency of resistance was found 
against tetracycline (79.3%), sulfonamide, florfenicol (64.9%), and ampicillin (64.3%) (Table 1). Five strains were resistant or 
intermediate to cefotaxime or ceftazidime (screening test), but only one of them was confirmed in the ESBL phenotypic test. 
However, three strains were positive in the PCR for blaTEM gene. No strain showed amplification for blaPSE gene. 
All the 240 typical colonies were confirmed by PCR as belonging to Enterococcus genus. From them, 217 (90.8%) were 
identified as E. faecalis by PCR. All isolates were susceptible to glycopeptides and ampicillin. The frequency of resistant 
strains against the tested antimicrobial is depicted in Table 2. Among the seventy-four erythromycin-intermediate strains, 
two had borderline MIC (4 µg/mL) while the other strains presented MIC between 1 µg/mL and 3 µg/mL. Among the sixty-
four resistant strains only six presented MIC between 6 and 64 µg/mL, and 58 presented MIC ≥ 256 µg/mL.
Discussion
Tetracycline resistance was the most frequent in both E. coli and Enterococcus isolated from all slaughterhouses included 
in this study. In Brazil, tetracycline resistance is widespread in Salmonella enterica isolated from pigs as demonstrated in 
previous studies (Bessa et al., 2004; Mürmann et al., 2009). Since all the three bacteria species colonize the intestine, they may 
be exposed to the same selection pressure exerted by the antimicrobial administration. Regarding E. coli, those tetracycline-
resistant strains presented resistance to sulfonamides and ampicillin as well, suggesting that genes the resistance may be 
located in mobile elements (Thorsteinsdottir et al., 2010). In our study this association was also observed in most E. coli 
strains tested, although the use of those antimicrobials as growth promoter has been banned since 1998 (Brasil, 2009). 
However, those antimicrobials are still used for treatment of highly prevalent respiratory and enteric diseases of swine. In this 
sense, the therapeutic use may have contributed to keep the selective pressure on bacterial population.
The frequency of antimicrobial use influences directly the selection of resistant strains (Wang et al., 2010); therefore variations 
in the protocol of their administration may justify differences in resistance profiles detected among the slaughterhouses. In 
Brazil, the pork supply chain is typically organized in a vertical integration system between large companies and small 
farms. Companies supply medicines and give technical assistance to the farmers and later on transport the market pigs to 
their own slaughterhouses. The large variation among slaughterhouses in the frequency of resistance against florfenicol 
and aminoglycosides in E.coli and Enterococcus strains, respectively, may illustrate the difference in treatment protocols. 
Specifically the increasing therapeutic use of florfenicol that has occurred in the last years may have contributed for the high 
percentage of resistant and intermediate strains observed.
Studies conducted in other countries demonstrated ESBL-resistant E. coli strains in feces of healthy pigs (Geser et al., 2011), 
pointing out the risk for carcass contamination. In our study, a low number of ESBL-resistant E.coli isolates was observed, 
indicating that this resistance phenotype is still not highly widespread in the region. Among five resistant strains, one was 
phenotypically confirmed, and three carried the blaTEM gene, demonstrating that they were potentially ESBL producers. In 
spite of the low frequency, the presence of ESBL-resistant strains in pigs highlights that further studies should be conducted 
to determine the prevalence and distribution of these strains.    
In this study, we included the genus Enterococcus, because of its importance as a reservoir of resistance genes against 
antimicrobials used for treatment of Gram-positive bacteria (Dzidic et al., 2008). In this regard, the reported the increase 
of vancomycin-resistant enterococci in animals have led to the ban of avorparcin administration to pigs in many countries. 
In Brazil, avoparcin had not been widely administered to pigs up until 1998, when its use was prohibited (Brasil, 1998). 
Therefore, the absence of resistant strains against glycopeptides was expected. Similar results have been reported in a nation-
wide monitoring program of poultry carcasses at retail level, where less than 1% of the Enterococcus strains were resistant to 
vancomycin and teicoplanin (ANVISA, 2008).      
On the other hand, the high frequency of erythromycin-resistant strains and the high MIC-levels (≥ 256 µg/mL) found is 
a matter of concern, since erm genes confer cross-resistance to the entire macrolide-lincosamides-streptogramins (MLSB) 
group, which constitute an important alternative for human treatment (Emanieni et al., 2008). Considering that studies 
demonstrated that common clones can colonize pigs and humans (Larsen et al., 2011), the widespread of resistant E. faecalis 
strains may constitute a hazard to public health. Recently the use of erythromycin as growth promoter has been banned in 
Brazil (Brazil, 2012), in order to avoid the selection of resistant strains. Nevertheless, erythromycin-resistance pattern should 
be kept under monitoring.   
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Conclusion
The results indicate that vancomycin-resistant Enterococcus isolates were not prevalent in pig carcasses; however ESBL 
producing E. coli may be present.
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Table 1 - Frequency of antimicrobial resistance in Escherichia coli isolated from pre-chill pig carcasses from three 
slaughterhouses (A, B, C) of Santa Catarina, Brazil.
A (n = 102) B (n = 122) C (n = 95) A, B, C (n = 319)
P value
R (%) I (%) R (%) I (%) R (%) I (%) R (%) I (%)
Ampicillin 71.57 1.96 65.57 10.65 54.74 11.58 64.26 8.15 0.023
Cefotaxime - 0.98 1.64 - 1.05 - 0.94 0.31 0.443
Ceftazime - - 1.64 - - - 0.62 - 0.197
Florfenicol 87.25 11.76 60.65 29.51 46.31 37.89 64.89 26.33 <0.001
Gentamicin 5.88 2.94 6.55 7.37 9.47 3.16 7.21 4.7 0.382
Nalidixic acid 75.49 0.98 48.36 4.1 50.53 5.26 57.68 3.44 <0.001
Sulfonamide 81.37 - 50.82 0.82 65.26 - 64.89 4.07 <0.001
Tetracycline 93.14 - 69.67 0.82 76.84 - 79.31 0.31 <0.001
Table 2 - Frequency of antimicrobial resistant Enterococcus isolated from pre-chill pig carcasses from three slaughterhouses 
(A, B, C) of Santa Catarina, Brazil.
A ( n = 84) B ( n = 74) C (n = 82) A, B, C (n = 240)
P valueR (%) I (%) R (%) I (%) R (%) I (%) R (%) I (%)
Ciprofloxacin 3.6 13.1 17.6 9.5 20.7 8.5 13.8 10.4 0.018
Cloramphenicol 27.4 3.6 2.7 1.4 4.9 2.4 12.1 2.5 <0.001
Erythromycin 41.7 42.9 10.8 20.2 25.6 25.6 26.7 30.8 <0.001
Gentamicin (HLAR) 17.9 - 2.7 - 9.8 - 10.4 - 0.008
Streptomycin (HLAR) 34.5 - 6.8 - 18.3 - 20.4 - <0.001
Tetracycline 45.2 - 48.6 2.7 34.1 2.4 42.5 1.7 0.209
